Evidence map›Paper›PMID 30633622›Full record

ArticleHuman vaccines & immunotherapeutics2019

Challenges and opportunities of school-based HPV vaccination in Canada.

Eve Dubé, Dominique Gagnon, Paule Clément, Julie A Bettinger, Jeannette L Comeau, Shelley Deeks, Maryse Guay, Shannon MacDonald, Noni E MacDonald, Hana Mijovic and 6 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 5 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 5 syntheses or guidelines pooled it, 83 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Eve Dubéa Département des risques biologiques et de la santé au travail, Institut national de santé publique du Québec (INSPQ) , Québec , QC , Canada.ORCID 0000-0003-1336-1510
Dominique Gagnona Département des risques biologiques et de la santé au travail, Institut national de santé publique du Québec (INSPQ) , Québec , QC , Canada.
Paule Clémenta Département des risques biologiques et de la santé au travail, Institut national de santé publique du Québec (INSPQ) , Québec , QC , Canada.
Julie A Bettingerd Vaccine Evaluation Center, BC Children's Hospital, University of British Columbia , Vancouver , British Columbia , Canada.ORCID 0000-0002-2118-4174
Jeannette L Comeaue Department of Pediatrics, Dalhousie University and IWK Health Centre , Halifax , Nova Scotia , Canada.
Shelley Deeksf Communicable Diseases, Emergency Preparedness and Response, Public Health Ontario , Toronto , Ontario , Canada.
Maryse Guaya Département des risques biologiques et de la santé au travail, Institut national de santé publique du Québec (INSPQ) , Québec , QC , Canada.
Shannon MacDonaldi Faculty of Nursing, University of Alberta , Edmonton , AB , Canada.ORCID 0000-0003-4675-4433
Noni E MacDonalde Department of Pediatrics, Dalhousie University and IWK Health Centre , Halifax , Nova Scotia , Canada.
Hana Mijovicd Vaccine Evaluation Center, BC Children's Hospital, University of British Columbia , Vancouver , British Columbia , Canada.
Jillian Paraggh Centre de recherche CSIS, Université de Sherbrooke , Longueuil , QC , Canada.
Clara Rubincamd Vaccine Evaluation Center, BC Children's Hospital, University of British Columbia , Vancouver , British Columbia , Canada.
Chantal Sauvageaua Département des risques biologiques et de la santé au travail, Institut national de santé publique du Québec (INSPQ) , Québec , QC , Canada.
Audrey Steenbecke Department of Pediatrics, Dalhousie University and IWK Health Centre , Halifax , Nova Scotia , Canada.
Sarah Wilsonf Communicable Diseases, Emergency Preparedness and Response, Public Health Ontario , Toronto , Ontario , Canada.ORCID 0000-0002-8239-0094
Canadian Immunization Research Network
Institut National de Santé Publique du Québec · CADalhousie University · CAUniversity of British Columbia · CAUniversité de Sherbrooke · CAUniversity of Toronto · CAUniversity of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary prevention of human papillomavirus (HPV) through vaccination is a high priority in Canada's cancer prevention efforts. All Canadian provinces and territories have introduced publicly funded, school-based vaccination programs against HPV, but vaccine uptake remains suboptimal in some jurisdictions. We conducted a descriptive qualitative study to better understand the determinants of low HPV vaccine uptake and identify strategies to enhance vaccine acceptance using the socio-ecological model. In Quebec, interviews and focus groups were held in 2015-2016 with 70 key informants including immunization managers, school nurses, school principals, teachers and parents of Grade 4 students (9 years of age). Our findings showed that HPV vaccine uptake was dependent on many interrelated factors at the individual and interpersonal level (e.g. knowledge and attitudes of the different players involved in the vaccination system), at the community level (e.g. social group values and norms, media coverage around the HPV vaccine), at the organizational level (e.g. allocated resources, information provision, consent process, immunization setting and environment) and at the policy level (e.g. changes in provincial HPV vaccine program). We are using the data collection and interpretation tools and approaches developed by our team and used in Quebec to expand our study to four other provinces (British Columbia, Alberta, Ontario and Nova Scotia). We are conducting environmental scans, semi-structured interviews and a survey to better understand the determinants of low HPV vaccine uptake and identify strategies to enhance vaccine acceptance. Having an in-depth understanding of the determinants of HPV vaccination in school settings is critical in order to identify root causes of the suboptimal vaccine uptake and to develop tailored interventions to address these on both supply- and demand-side issues.

Indexed as

Immunization ProgramsSchoolsHealth Knowledge, Attitudes, PracticeHumansPapillomavirus InfectionsParentsPatient Acceptance of Health CareQuebecSchool TeachersStudentsVaccinationdeterminantsHPV vaccineimmunization managersinterviewsschool-based immunization programssocio-ecological model

Identifiers

PMID30633622
PMCPMC6746476
OpenAlexW2915390665

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.